Fig. 4From: Time and productivity loss associated with immunotherapy infusions for the treatment of melanoma in the United States: a survey of health care professionals and patientsAverage, minimum, and maximum time per infusion visit that patients reported their caregivers spent with them: for (A) Unpaid caregivers (N = 20) and (B) Paid caregivers (N = 41)Back to article page